EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A 3D Bioprinted Human Neurovascular Unit Model of Glioblastoma Tumor Growth

Yen-Ting Tung, Yu-Chi Chen, Kristy Derr, Kelli Wilson, Min Jae Song iD, Marc Ferrer

Advanced Healthcare Materials · 2024-06 · 13 (15)

DOI: 10.1002/adhm.202302831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.03.2024. Verfasst von Yen-Ting Tung und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD, 20850, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Printing, Three-Dimensional. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 3D bioprinted neurovascular unit (NVU) model is developed to study glioblastoma (GBM) tumor growth in a brain‐like microenvironment. The NVU model includes human primary astrocytes, pericytes and brain microvascular endothelial cells, and patient‐derived glioblastoma cells (JHH‐520) are used for this study. Fluorescence reporters are used with confocal high content imaging to quantitate real‐time microvascular network formation and tumor growth. Extensive validation of the NVU‐GBM model includes immunostaining for brain relevant cellular markers and extracellular matrix components; single cell RNA sequencing (scRNAseq) to establish physiologically relevant transcriptomics changes; and secretion of NVU and GBM‐relevant cytokines. The scRNAseq reveals changes in gene expression and cytokines secretion associated with wound healing/angiogenesis, including the appearance of an endothelial mesenchymal transition cell population. The NVU‐GBM model is used to test 18 chemotherapeutics and anti‐cancer drugs to assess the pharmacological relevance of the model and robustness for high throughput screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsPrinting, Three-DimensionalHumansCell Line, TumorBioprintingTumor MicroenvironmentEndothelial CellsAstrocytesPericytesNeovascularization, Pathologic

Stichwörter der Autor:innen

3D Bioprintingglioblastomashigh‐throughput screeningneurovascular unittranscriptomics

Autor:innen und Institutionen

  • National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD, 20850, USA.

ORCID-Profile: Min Jae Song

Förderung

  • Intramural NIH HHS

Zitieren

APA

Tung, Y. T., Chen, Y. C., Derr, K., Wilson, K., Song, M. J., & Ferrer, M. (2024). A 3D Bioprinted Human Neurovascular Unit Model of Glioblastoma Tumor Growth. Advanced Healthcare Materials, 13(15). https://doi.org/10.1002/adhm.202302831

Vancouver

Tung YT, Chen YC, Derr K, Wilson K, Song MJ, Ferrer M. A 3D Bioprinted Human Neurovascular Unit Model of Glioblastoma Tumor Growth. Advanced Healthcare Materials. 2024;13(15). doi:10.1002/adhm.202302831

BibTeX
@article{Tung2024,
  author = {Tung, Yen-Ting and Chen, Yu-Chi and Derr, Kristy and Wilson, Kelli and Song, Min Jae and Ferrer, Marc},
  title = {A 3D Bioprinted Human Neurovascular Unit Model of Glioblastoma Tumor Growth},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {15},
  doi = {10.1002/adhm.202302831}
}
Kostenlos starten →